Publications scientifiques Bordet

Publications scientifiques Bordet

  • What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.

  • Auteurs Linares Díaz J, Edwards J, Deleu AL, Giaj-Levra N, Prisciandaro E, Roch B, Paesmans M, Berghmans T, Brandão M
  • Auteurs (entité) DELEU ANNE-LEEN
  • Revue Cancers (Basel)
  • Date de publication 2024-07
What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.
  • What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.

  • Auteurs Linares Díaz J, Edwards J, Deleu AL, Giaj-Levra N, Prisciandaro E, Roch B, Paesmans M, Berghmans T, Brandão M
  • Auteurs (entité) BERGHMANS THIERRY
  • Revue Cancers (Basel)
  • Date de publication 2024-07
What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment.
  • Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma-Final Analysis.

  • Auteurs Maerevoet M, Casasnovas O, Cartron G, Morschhauser F, Thieblemont C, Bouabdallah K, Feugier P, Szablewski V, Becker S, Tilly H
  • Auteurs (entité) MAEREVOET MARIE
  • Revue Cancers (Basel)
  • Date de publication 2024-07
Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma-Final Analysis.
  • A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.

  • Auteurs Caballero C, Lundon DJ, Vasileva-Slaveva M, Montagna G, Bonci EA, Brandl A, Smith H, Kok JHH, Holmberg CJ, Sayyed R, Santrac N, Suppan I, Kaul P, Vassos N, Lorenzon L, Murphy M, Ceelen W, de Azambuja E, McIntosh SA, Rubio IT
  • Auteurs (entité) DE AZAMBUJA EVANDRO
  • Revue Eur J Surg Oncol
  • Date de publication 2024-08
A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
  • Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study.

  • Auteurs Berghuis D, Mehyar LS, Abu-Arja R, Albert MH, Barnum JL, von Bernuth H, Elfeky R, Lewalle P, Laberko A, Ghosh S, Slatter MA, Weemaes CMR, Yesilipek A, Sirait T, Neven B, Gennery AR, Lankester AC
  • Auteurs (entité) LEWALLE PHILIPPE
  • Revue J Clin Immunol
  • Date de publication 2024-08
Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party Study.
Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet